Pirfenidone	NN
inhibits	VBZ
the	DT
expression	NN
of	IN
HSP47	NN
in	IN
TGF-beta1-stimulated	JJ
human	JJ
lung	NN
fibroblasts	NNS
.	.

Pirfenidone	NN
(	(
5-methyl-1-phenyl-2	NN
-	:
(	(
1H	NN
)	)
-	:
pyridone	NN
)	)
is	VBZ
a	DT
novel	JJ
anti-fibrotic	JJ
and	CC
anti-inflammatory	JJ
agent	NN
that	WDT
inhibits	VBZ
the	DT
progression	NN
of	IN
fibrosis	NN
in	IN
animal	NN
models	NNS
and	CC
patients	NNS
with	IN
idiopathic	JJ
pulmonary	JJ
fibrosis	NN
(	(
IPF	NN
)	)
.	.

Heat	NN
shock	NN
protein	NN
(	(
HSP	NN
)	)
47	CD
,	,
a	DT
collagen-specific	JJ
molecular	JJ
chaperone	NN
,	,
is	VBZ
involved	VBN
in	IN
the	DT
processing	NN
and/or	CC
secretion	NN
of	IN
procollagen	NN
and	CC
plays	VBZ
an	DT
important	JJ
role	NN
in	IN
the	DT
pathogenesis	NN
of	IN
IPF	NN
.	.

The	DT
present	JJ
study	NN
evaluated	VBD
the	DT
in	FW
vitro	FW
effects	NNS
of	IN
pirfenidone	NN
on	IN
expression	NN
of	IN
HSP47	NN
and	CC
collagen	NN
type	NN
I	CD
in	IN
cultured	VBN
normal	JJ
human	JJ
lung	NN
fibroblasts	NNS
(	(
NHLF	NN
)	)
.	.

Expression	NN
levels	NNS
of	IN
HSP47	NN
and	CC
collagen	NN
type	NN
I	CD
in	IN
NHLF	NN
stimulated	VBN
by	IN
transforming	VBG
growth	NN
factor	NN
(	(
TGF	NN
)	)
-	:
beta1	NN
were	VBD
evaluated	VBN
genetically	RB
,	,
immunologically	RB
and	CC
immunocytochemically	RB
.	.

Treatment	NN
with	IN
TGF-beta1	NN
stimulated	VBD
both	CC
mRNA	NN
and	CC
protein	NN
expressions	NNS
of	IN
both	DT
HSP47	NN
and	CC
collagen	NN
type	NN
I	CD
in	IN
NHLF	NN
,	,
and	CC
pirfenidone	NN
significantly	RB
inhibited	VBD
this	DT
TGF-beta1-enhanced	JJ
expression	NN
in	IN
a	DT
dose-dependent	JJ
manner	NN
.	.

We	PRP
concluded	VBD
that	IN
the	DT
anti-fibrotic	JJ
effect	NN
of	IN
pirfenidone	NN
may	MD
be	VB
mediated	VBN
not	RB
only	RB
through	IN
direct	JJ
inhibition	NN
of	IN
collagen	NN
type	NN
I	CD
expression	NN
but	CC
also	RB
at	IN
least	JJS
partly	RB
through	IN
inhibition	NN
of	IN
HSP47	NN
expression	NN
in	IN
lung	NN
fibroblasts	NNS
,	,
with	IN
a	DT
resultant	JJ
reduction	NN
of	IN
collagen	NN
synthesis	NN
in	IN
lung	NN
fibrosis	NN
.	.

